Strategic Initiative

Slingshot members are tracking this corporate initiative:

Akebia Therapeutics (AKBA) Announces Exclusive License Agreement with Janssen Pharma (JNJ) for Portfolio Targeting Hypoxia-Inducible Factors (HIF)

Source Link:
http://ir.akebia.com/releasedetail.cfm?ReleaseID=1011522

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
JNJ
100%
AKBA
100%
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Strategic Initiative Date
Announcement Date:
Feb 13, 2017
Projected Implementation:
Q2, 2017
Relevance Tracked Until:
Q2, 2019
Related Projects Image

  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Exclusive Agreement, Hypoxia-inducible Factor
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.